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Abstract: In the current study, the prevalence of the most common psychological disorders 
in COPD patients and their spouses was assessed cross-sectionally. The inﬂ  uence of COPD 
patients’ and their spouses’ psychopathology on patient health-related quality of life was also 
examined. The following measurements were employed: Forced expiratory volume in 1 second 
expressed in percentage predicted (FEV1%), Shuttle-Walking-Test (SWT), International 
Diagnostic Checklists for ICD-10 (IDCL), questionnaires on generic and disease-speciﬁ  c health-
related quality of life (St. George’s Respiratory Questionnaire (SGRQ), European Quality of 
Life Questionnaire (EuroQol), a modiﬁ  ed version of a Disability-Index (CDI)), and a screening 
questionnaire for a broad range of psychological problems and symptoms of psychopathology 
(Symptom-Checklist-90-R (SCL-90-R)). One hundred and forty-three stable COPD outpatients 
with a severity grade between 2 and 4 (according to the GOLD criteria) as well as 105 spouses 
took part in the study. The prevalence of anxiety and depression diagnoses was increased both 
in COPD patients and their spouses. In contrast, substance-related disorders were explicitly 
more frequent in COPD patients. Multiple linear regression analyses indicated that depression 
(SCL-90-R), walking distance (SWT), somatization (SCL-90-R), male gender, FEV1%, and 
heart disease were independent predictors of COPD patients’ health-related quality of life. After 
including anxiousness of the spouses in the regression, medical variables (FEV1% and heart 
disease) no longer explained disability, thus highlighting the relevance of spouses’ well-being. 
The results underline the importance of depression and anxiousness for health-related quality of 
life in COPD patients and their spouses. Of special interest is the fact that the relation between 
emotional distress and quality of life is interactive within a couple.
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Introduction
Comorbid symptoms of anxiety and depression are common in patients with chronic 
obstructive pulmonary disease (COPD) (Yohannes et al 2006) and cause a number of 
negative effects. Compared with non-depressed COPD patients, COPD patients with 
elevated depression scores show lower health-related quality of life (Mikkelsen et al 
2004; Yohannes et al 2006; Ng et al 2007), a lower level of functioning (Kim et al 2000), 
longer and more frequent hospital stays (Ng et al 2007), and increased mortality, as 
shown in prospective studies (Crockett et al 2002; Ng et al 2007). Similarly, increased 
levels of anxiety lead to impairment of quality of life (Kim et al 2000; Di Marco et al 
2006) and more frequent hospital admissions in COPD patients (Gudmundsson et al 
2005; Yohannes et al 2005). However, the reported prevalence rates for comorbid 
symptoms of depression or anxiety are highly variable: in studies using anxiety and 
depression self-report questionnaires, these rates range from 13% and 7% (Engström 
et al 2001) to 96% and 79%, respectively (Borak et al 1991; Hynninen et al 2005). 
The few studies that assessed categorical diagnoses by means of international diagnosis 
systems such as the ICD-10 (WHO 1993) or the DSM-III-R/-IV (Saß et al 1996) also International Journal of COPD 2008:3(4) 728
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reported inconsistent but lower prevalence rates, ranging 
from 10% to 35% and 16% to 47%, respectively (Yellowlees 
et al 1987; Karajgi et al 1990; Aghanwa and Erhabor 2001; 
Aydin and Ulusahin 2001; Stage et al 2003). However, the 
generalization of these results is limited by the small sample 
sizes and the absence of control groups.
The inconsistency of previous ﬁ  ndings may partly be 
due to varying inclusion criteria (eg, COPD grade 1–4, out-
patients versus in-patients, stable or with exacerbation, with 
or without oxygen therapy) research strategies, and employed 
instruments. The use of screening questions that are highly 
sensitive to detect symptoms of anxiousness and dysphoria 
generally result in an extremely high proportion of individuals 
screened positive (Kunik et al 2005). In contrast, self-report 
questionnaires assessing levels of symptomatology result in a 
smaller proportion of potentially disordered individuals. The 
presence of a clinically signiﬁ  cant mental disorder, however, 
can be determined only on the basis of categorical diagnostics 
according to international classiﬁ  cation systems such as the 
ICD-10 (WHO 1993). These diagnoses are based on a deﬁ  ned 
set of symptom criteria. Precise case deﬁ  nition criteria for 
each symptom (severity, frequency, duration) as well as 
explicit inclusion and exclusion criteria usually result in high 
inter-rater reliabilities. Thus, categorical diagnostics can be 
considered the gold standard in diagnosing mental disorders. 
Overall, though, few studies have employed such elaborate 
classiﬁ  cation systems of mental disorders, and even fewer 
have compared their results with those of control groups (eg, 
Aghanwa and Erhabor 2001; Lin et al 2005).
It is well documented that spouses of patients with other 
severe and life-threatening somatic diseases may encounter 
comparable psychosocial and emotional distress as the 
patients themselves. However, very few COPD studies 
have addressed this issue (Kim et al 2000; Kanervisto 
et al 2007; Pinto et al 2007). In two studies, the spouses of 
COPD patients reported levels of loneliness and depressive 
mood comparable to the levels reported by the patients 
themselves (Keele-Card et al 1993; Kara et al 2004). To our 
knowledge, there have been no studies on the prevalence of 
mental disorders in spouses of COPD patients, even though 
their state of health may be of particular importance for the 
supportive care of patients.
The ﬁ  rst purpose of the present study was to compare 
the prevalence of mental disorders in COPD patients with 
the prevalence in two reference groups of elderly persons. 
The second purpose was to investigate the prevalence of 
mental disorders in the spouses. Speciﬁ  cally, we examined 
the following questions: (1) Does the psychopathology 
of the patients and that of their spouses correlate with the 
health-related quality of life of the patients? (2) How is 
the COPD-related disability of spouses related to clinical 
variables of patients?
Methods
Measures
First, a bodyplethysmography (MasterScreenBody by Viasys/
Jaeger) was performed, in accordance with the American 
Thoracic Society guidelines, as well as a shuttle walking test 
(Singh et al 1992; Dyer et al 2002). The subjects performed 
only one test at baseline. Three to 10 days later, psychological 
diagnostics were carried out in the homes of the COPD patients 
by a clinical psychologist (Kerstin Kühl), who was blind to the 
results of lung function testing. At the beginning of the home 
assessment, patients and their spouses underwent a screening 
interview to assess for the presence of cardinal symptoms of 
depressive disorders (ICD-10 diagnosis of depressive episode 
[F32] or recurrent depressive disorder [F33]), dysthymia, panic 
disorder, agoraphobia, generalized anxiety disorder, as well as 
nicotine and alcohol abuse. For participants screened positive, 
categorical diagnostics (International Diagnostic Checklists 
for ICD-10) (Hiller et al 1997) were used. Subsequently, the 
following questionnaires were applied:
The St. Georges Respiratory 
Questionnaire (SGRQ) 
(German version: Hütter 2003)
The SGRQ assesses the subjective quality of life of COPD 
patients. Thus it cannot be rated by the spouses.
COPD Disability Index (CDI)
In contrast, COPD-related disability assessing reductions 
of social functioning and self-care can be rated both by 
patients and their spouses. The CDI is an adaptation of 
the Pain Disability Index (PDI) (Dillmann et al 1994). 
The original version comprises 7 items: family/home, 
responsibilities, recreation, social activity, occupation, sexual 
behavior, self-care, and life-support activities (breathing, 
sleeping, eating). For the purpose of the present study, 
item 7 (breathing, sleeping, eating) was limited to breathing. 
Since COPD is a respiratory disease, breathing, eating, and 
sleeping are affected differently and thus cannot be averaged 
in this study population. The degree of disability caused 
by the disease is rated on an 11-point rating scale for all 
respective aspects of life. In general, factor analyses with 
different patient groups and with spouses of pain patients International Journal of COPD 2008:3(4) 729
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have yielded one factor and conﬁ  rmed the unidimensionality 
of the construct (Dillmann et al 1994), although there have 
been two exceptions (Tait et al 1987; Tait and Chibnall 2005). 
Spouses were instructed to evaluate their perceived disability 
due to their partner’s illness.
The European Quality of Life 
Questionnaire (EuroQol) 
(Schulenburg et al 1998)
The EuroQol assesses the generic health-related quality of life 
by means of a visual analogue scale. The scale ranges from 
0 (“the worst state of health to be imagined”) to 100 (“the best 
state of health to be imagined”).
The Symptom-Checklist-90-R (SCL-90-R) 
(Franke 2000)
The SCL-90-R assesses physical and psychological symptoms 
within the last week. Only subscales that are relevant for the 
issue under investigation (depression, anxiousness, phobic 
anxiety, somatization) were included in the analysis. Two 
items of the somatization scale (chest pain and breathing 
difﬁ  culties) were excluded, since these symptoms might 
reﬂ  ect actual symptoms of COPD rather than symptoms of 
psychopathology.
Statistical analysis
The data was analysed using SPSS (v. 15.0. SPSS Inc., 
Chicago, IL). Internal consistency for the modified 
COPD-Disability-Index (CDI) was determined using 
Cronbach’s alpha. Of particular note was the high internal 
consistency in the CDI (P-CDI = 0.92; S-CDI (without item 
7 breathing) = 0.86) (For reasons of clarity, variables assessed 
on COPD patients and their spouses will be labeled with 
P [for COPD patients’ data] and S [for spouses’ data].)The 
significant Pearson correlations between COPD-related 
disability (P-CDI) and the SGRQ in patients (SGRQ-S 
r = 0.59; SGRQ-A r = 0.74; SGRQ-I r = 0.81; SGRQ-T 
r = 0.83; all p   0.01) support the convergent validity of 
this new instrument. In addition, the signiﬁ  cant associations 
between COPD-related disability in the spouses (S-CDI) 
and the SGRQ in the patients (SGRQ-S r = 0.35; SGRQ-A 
r = 0.45; SGRQ-I r = 0.59; SGRQ-T r = 0.56; all p   0.01) 
not only highlight the relationship between patient’s health 
and partner’s disability, but conﬁ  rm that the CDI is a very 
short but nonetheless reliable and valid instrument.
The results of our patient and spouse samples 
will be compared with normative data of two representa-
tive samples of elderly persons (Wernicke et al 2000; 
Trollor et al 2007). Comparisons for patients with and 
without mental disorders were computed by means of 
t-tests for independent samples and chi square tests. For 
nonparametrical variables Mann-Whitney U-test were anal-
ysed. Recent research (eg, Chavannes et al 2005; Cully et al 
2006; Di Marco et al 2006; Ng et al 2007) has highlighted 
nine variables (FEV1, walking distance, gender, heart disease, 
somatization, anxiousness, depression (SCL-90-R), phobic 
anxiety (SCL-90-R), depression/anxiety diagnoses) as 
relevant predictors of health-related quality of life in patients 
with COPD. These variables were included in a stepwise 
multiple linear regression to predict patients’ health-related 
quality of life (SGRQ). Furthermore, the part of explained 
variance of the COPD-related disability of the spouses 
(S-CDI) was calculated.
Patient sample
Over a period of 9 months, all COPD patients of a private 
pulmonary practice were consecutively asked if they wanted 
to take part in the study. Patients with a severity grade of 2, 
3, or 4 (according to the GOLD criteria) who had been at 
the routine appointment 3 respectively 6 months before were 
included. All participants received €10 and a small present 
(candy) as reimbursement for their participation. Exclusion 
criteria were, for patients, illness exacerbation within the 
previous month or, for patients and spouses, a severe acute 
illness (such as myocardial infarction, tumor) within the 
last year. Of the 165 COPD patients who were approached, 
only 15 (9.1%) declined to participate. Ten participants – 7 
patients (4.2%) and 3 spouses (2.7%) – had to be excluded 
for reasons of illness exacerbation (2), diagnosis of tumor 
(3), psychosis (1), missing data (1), possible dementia (2), 
or insufﬁ  cient language abilities (1). Another couple was 
excluded from the comparison of couples because both were 
COPD patients. Thus, 143 COPD patients (and 105 spouses) 
were included in the analysis. The duration of illness was 
less than one year in 4.6% of patients, 1–3 years in 12.8% 
of patients, 3–10 years in 12.8 % of patients, and more than 
10 years in 50.5% of patients. Within 12 months prior to the 
study, 15 patients (10.5%) had been admitted to hospital due 
to COPD exacerbation and two (1.4%) to a comprehensive 
pulmonary rehabilitation.
Results
Comorbid mental disorders
Most of the 143 COPD patients (80.4%/75.2% of the spouses) 
did not fulﬁ  l the criteria of any of the investigated depressive 
or anxiety disorders (Table 2).International Journal of COPD 2008:3(4) 730
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COPD patients and their spouses were compared with 
a representative German aging study, which also used 
categorical diagnoses (Wernicke et al 2000). The prevalence 
rates for anxiety and depressive disorders (except for 
dysthymia) were higher than in the reference sample for 
both patients and their spouses (see Table 2). Only ﬁ  ve out 
of these 29 patients were taking psychotropic medication 
and no patients were receiving any form of psychological 
support or psychotherapeutic treatment. The prevalence 
of anxiety or depressive disorders was not influenced 
by COPD severity (grade 2 = 23.6%; grade 3 = 26.5%; 
grade 4 = 18.2%; χ2 = 0.23, df = 2, p = n.s.). In the present 
study, 7.7% of COPD patients met criteria for alcohol 
abuse and/or dependence. Although this rate was lower 
than reported by Stage et al (2003), it was signiﬁ  cantly 
higher compared with two reference samples (Wernicke 
et al 2000; Trollor et al 2007).
As expected, only 4.9% of the patients had always 
been non-smokers, compared with 61.9% of the spouses. 
This difference is signiﬁ  cant and cannot be explained by gender 
differences (females, Pearson’s χ2 = 51.26, df = 2, p   0.001; 
males, Pearson’s χ2 = 14.40, df = 2, p   0.001). The percentage 
of participants with clinically relevant SCL-90-R T-scores 
(ie, those with scores   mean + 1 SD) was signiﬁ  cantly higher 
in patients compared to spouses: somatization, 39.2% (vs 21.9%, 
Pearson’s χ2 = 8.31, df = 1, p   0.004), depression (SCL-90-R), 
29.4% (vs 16.2%, Pearson’s χ2 = 5.80, df = 1, p   0.016), 
anxiousness, 25.2% (vs 15.2%, Pearson’s χ2 = 3.61, df = 1, p 
  0.057), and phobic anxiety (SCL-90-R), 18.2% (vs 5.7%, 
Pearson’s χ2 = 8.37, df = 1, p   0.004). There was a low but 
signiﬁ  cant positive correlation between self-reported duration 
of illness and all SCL-90-R subscales – even after controlling 
for age and FEV1% (partial correlation: somatization rp = 0.24, 
depression rp = 0.24, anxiousness rp = 0.20, phobic anxiety 
rp = 0.22; all p   0.05).
Quality of Life
It is important to note that the quality of life was 
considerably lower compared to the general 1 (EuroQol: 
CI = 76.3–77.1–77.9) in both patients (EuroQol: 
CI = 46.6–50.2–53.9) and spouses (EuroQol: CI = 62.6–66.5–
70.5). COPD patients with mental disorders reported 
signiﬁ  cantly higher scores on subscales for psychosocial 
impact (SGRQ-I) and health related quality of life 
(SGRQ-T) than patients without mental disorders (see 
Table 3). There was no difference between COPD patients 
with and without mental disorders with regard to socio-
demographic variables (age, gender), restriction of lung 
functioning (FEV1%), walking distance, or general health-
related quality of life (EuroQol).
Table 1 Sample characteristics
Patients (n = 143) Spouses (n = 105)
Age (years) 67.0 ± 9.5 range: 40–90 64.0 ± 9.3 range: 43–84
Gender (F:M) 31:112 (21.7 : 78.3%) 19:86 (81.9 : 18.1%)
Marital status
 Single 8  (5.5%)
 Separated 11  (7.7%)
 Widowed 14  (9.8%)
 Married 110  (76.9%) 105 (100%)
  Years of marriage 37.8 ± 12.8 range: 4–66
Education
   9 years 110 (76.9%) 86 (80.1%)
  10 years 19 (13.3%) 14 (9.8%)
  13 years 14 (9.8%) 5 (3.5%)
COPD severity FEV1% pred SWT Comorbid heart disease
2 n  = 68 (47.6 %) 62.9 ± 9.6 402 ± 241 n = 30 (44.1%)
3 n  = 62 (43.4 %) 40.8 ± 5.3 219 ± 161 n = 28 (45.2%)
4 n  = 13 (9.1 %) 26.4 ± 2.8 118 ± 133 n = 5 (38.5%)
Data presented as n, mean ± SD
Abbreviations: FEV1% pred, forced expiratory volume in 1 second expressed in percentage predicted; SWT, shuttle walking test (in meters); comorbid heart disease, coronary 
heart disease, myocardial infarction or cardiac failure.International Journal of COPD 2008:3(4) 731
Mental disorders and quality of life in COPD couples
The nine variables (FEV1, walking distance, gender, 
heart disease, somatization, anxiousness, depression 
(SCL-90-R), phobic anxiety (SCL-90-R), depression/
anxiety diagnoses), which had previously been identiﬁ  ed 
as relevant predictors of health-related quality of life in 
patients with COPD, were included in a multiple regression 
model to predict health-related quality of life (SGRQ-T; 
Table 4).
The present study identiﬁ  ed 6 variables (Table 4, model 
A, adjusted R2 = 0.64, p   0.001) as signiﬁ  cant predictors of 
health-related quality of life. In a second regression analysis, 
spouse variables were included in addition to the above listed 
patient variables (model B, adjusted R2 = 0.62, p   0.001). 
The greatest proportion of variance in both models was 
explained by the patients’ depression scores (SCL-90-R), 
walking distance (SWT), somatization, and male gender. In 
model B, spouses’ anxiousness was a signiﬁ  cant predictor 
of patients’ health related quality of life, while the objective 
measures FEV1% and heart disease were not found to be 
signiﬁ  cant predictors.
In addition, we analyzed whether the predictor variables 
from the ﬁ  rst regression analysis (model A) would also 
predict spouses’ perceived disability due to their partners’ 
illness (criterion: S-CDI) (Table 4). Twenty-seven percent of 
the variance (model C, adjusted R2 = 0.27, p   0.001) of the 
S-CDI was explained by the patient variables somatization, 
walking distance (SWT), and depression (SCL-90-R), again 
conﬁ  rming the close relationship of the partner’s well-being 
with patients’ health.
In the fourth regression analysis psychosocial impact of the 
COPD patients in the SGRQ and the extent of other physical 
symptoms (P-somatization) predicted COPD-related disability 
in the spouses (model D, adjusted R2: 0.36, p   0.001).
Discussion
The present study investigated the prevalence of mental 
disorders and quality of life in 143 consecutive COPD 
patients attending a private pulmonary practice as well as 
105 spouses.
1.  Results revealed significantly increased prevalence 
rates for depressive disorders, anxiety disorders, and 
alcohol related disorders in COPD patients compared to 
a representative German reference sample (Wernicke et al 
2000) and a German aging study (DHS 2005). Similarly, 
increased prevalence rates for depressive and anxiety 
disorders were found in patients’ spouses.
The high rates of alcohol abuse and dependence in 
patients in this study might be a result of more genuine 
response tendencies: during the screening of substance-
related disorders – and only at this point – some of the 
spouses intervened and urged their partners to be more 
honest about the amount of alcohol consumption (Stage 
et al 2003).
Table 2 Comorbid mental disorders in COPD patients and their spouses
2 representative samples Signiﬁ  cance Pearson’s χ2
Patients 
(n = 143)
BASE 
(n = 516)
NMHWS 
(n = 1792)
Spouses 
(n = 105)
BASE/
Patients
BASE/
Spouses
Anxiety/depression diagnoses:
  Depressive disorder 17 (11.9 %) 4.8 % 1.1 % 18 (17.1 %) p   .003 p   .001
  Dysthymia 3 (2.1 %) 2.0 % 0.1 % 4 (2.8 %) n.s. n.s.
  Panic disorder and/or agoraphobia 11 (7.7 %) 0.8 % 0.5 % 5 (4.8 %) p   .001 p   .001
  Generalized anxiety disorder 8 (5.6 %) 0.9 % 1.7 % 7 (6.7 %) p   .001 p   .001
Alcohol dependence or harmful use:
  At present 11 (7.7 %) 1.2 % 0.3 % 1 (1.0 %) p   .001 n.s.
  Lifetime 14 (9.8 %) 2 (2.0 %)
  Non-existent 118 (82.5 %) 102 (97.1 %)
Nicotine dependence or abuse:
  At present 31 (21.7 %) not assessed 23 (21.9 %)
  Former smoker 105 (73.4 %) 17 (16.2 %)
  Non-smoker 7 (4.9 %) 65 (61.9 %)
Abbreviations: BASE, German Aging Study (data are DSM-III-R diagnoses according to Wernicke et al 2000); NMHWS, national mental health and well-being-survey (data 
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2.  The second aim of this study was to investigate pre-
dictors of quality of life in COPD patients and their 
spouses. Results identified 6 out of 9 theoretically 
derived variables (somatization, depression [SCL-90-R], 
walking distance [SWT], gender, FEV1%, heart disease) 
as signiﬁ  cant predictors of health-related quality of life 
in COPD patients. When including spouse variables, 
the objective variables (FEV1%, heart disease) failed to 
remain signiﬁ  cant predictors for patients’ quality of life, 
while symptoms of anxiousness in spouses explained 
substantial variance. This emphasizes the importance of 
spouses’ anxiousness for the health-related quality of life 
in the patients.
3. On the other hand, 36% of the total variance in 
spouses’ COPD-related disability could be explained by 
disease-speciﬁ  c psychosocial impact (SGRQ-I) and the 
physical condition of the patients (somatization). This is 
a further indication that spouses of COPD patients are 
substantially affected by the disease of their partners, 
a fact that previous studies have already highlighted 
(Keele-Card et al 1993; Kara et al 2004; Kanervisto et al 
2007; Pinto et al 2007).
Limitations
Our study has several limitations. First, despite a com-
prehensive psycho-diagnostic assessment, the number of 
investigated diagnoses was limited in the present study. 
Second, some diagnostic criteria were difﬁ  cult to evaluate 
in this patient group. For example, in order to receive a 
diagnosis of panic disorder, symptoms must not be due to 
a medical condition. In the case of patients with comorbid 
heart disease or severe dyspnea this is difﬁ  cult to decide. 
Third, the cross-sectional design of this study does not 
allow conclusions to be drawn about the causal relationship 
between COPD, psychological disorders, and quality of 
life in the patients or psychological diagnoses and quality 
of life in the spouses. Furthermore, no conclusions can be 
drawn about the causal relation between patient variables 
and psychological disorders or quality of life in their 
spouses. Fourth, patients included in this study were stable 
out-patients at a private pulmonary practice. The present 
results may thus not be generalized to hospitalized patients 
or patients with acute exacerbation.
Implications
Diagnostic
The extensive diagnostic assessment according to ICD-10 
was only conducted with respect to diagnoses which have 
frequently been investigated in COPD patients. It is likely 
that alcohol dependency is a comorbid disorder which so far 
has not received enough attention.
It is important to point out that a considerate number of 
patients who did not fulﬁ  l criteria for a current diagnosis 
reported having experienced severe symptoms of depression 
or anxiety on a few days in the past year (often during 
periods of COPD exacerbation). However, if a patient fulﬁ  ls 
Table 3 Comparison of means in COPD patients with and without mental disorders
Patients with mental 
disorder (n = 28)
Patients without mental 
disorder (n = 115)
M SD M SD test statistics df Sig. 1-sided
Gendera (F:M) 8 : 20 23 : 90 n.s
Age (years) 67.0 9.6 64.0 9.3 n.s.
SWT 298 221 297 227 n.s.
FEV1% pred 50.3 15.6 50.0 14.8 n.s.
SGRQ
 Symptoms 57.7 25.1 63.8 22.9 n.s.
 Activities 65.2 25.6 60.0 22.6 n.s.
 Impact 64.9 37.1 49.1 30.1 −2.37 141 0.010
 Total  score 64.8 29.1 53.8 24.6 −2.04 141 0.022
EuroQolb 43.9 29.5 51.8 19.9 n.s.
CDI 5.27 2.83 4.25 2.86 n.s.
Test statistics are t-tests, if not otherwise speciﬁ  ed.
aχ2; bMann-Whitney U-Score.
Abbreviations: SWT, shuttle walking test; FEV1% pred, forced expiratory volume in 1 second expressed in percentage predicted; SGRQ, st. george’s respiratory questionnaire; 
EuroQol, european quality of life questionnaire; CDI, COPD-disability-index.International Journal of COPD 2008:3(4) 733
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all symptoms necessary for a diagnosis of depression for 
only 9 days, a diagnosis of depression (ICD-10 F32) can-
not be given. Similarly, in panic disorder (ICD-10 F41.0) 
symptoms must not be due a medical factor in order to meet 
diagnostic criteria. For a diagnosis of Generalized Anxiety 
Disorder (GAD), worries have to be disproportionate or 
unreasonable. In the present study, health-related worries did 
not count toward a diagnosis of GAD. This might account 
for the low prevalence rate of GAD in this study (5.6%) 
compared with 10%–15.8% (Yellowlees et al 1987; Karajgi 
et al 1990; Aghanwa and Erhabor 2001) found in former 
studies. The prevalence of GAD found in this sample might 
thus underestimate the scale of clinically relevant anxiety 
and worries.
Even if some of the reported symptoms did not meet 
diagnostic criteria for the above mentioned reasons, they 
still reﬂ  ect clinically relevant psychopathology (Rief et al 
2005). Such clinically relevant syndromes can be diagnosed 
according to ICD-10, for example as adjustment disorder, and 
anxiety or mood disorder due to a general medical condition 
(Figure 1).
The DSM-IV explicitly mentions COPD for anxiety 
disorder due to a medical condition (Frances et al 1995) and 
assumes that anxiety may be a direct result of the chronic 
hyperventilation pattern or of neurobiologically increased CO2 
sensitivity (Dratcu 2000; Mikkelsen et al 2004). Therefore, 
these diagnoses should be considered more rigorously in future 
COPD studies.
Table 4 Stepwise multiple linear regressions
criterion: health-related quality of life in patients (SGRQ-T)
Model A: only patient variables Model B: patient and spouse variables
Signiﬁ  cant Predictors: β p Signiﬁ  cant Predictors: β p
P-Depression 
(SCL-90-R)
0.32  0.001 P-Somatizationa 
(SCL-90-R)
0.22 0.015
Walking distance 
(SWT)
−0.36  0.001 Walking distance 
(SWT)
−0.53  0.001
P-Somatizationa 
(SCL-90-R)
0.27  0.001 P-Depression 
(SCL-90-R)
0.30  0.001
P-Gender 
(1 = F; 2 = M)
0.14 0.009 S-Anxiousness 
(SCL-90-R)
0.16 0.024
FEV1% pred −0.15 0.014 P-Gender 
(1 = F; 2 = M)
0.14 0.028
Heart disease 0.13 0.027
Excluded variables: 
SCL-90-R: P-Anxiousness, P-Phobic anxiety; P-depression/anxiety 
diagnoses
Excluded variables: 
FEV1% pred; heart disease; S-Gender; SCL-90-R: S-Somatization, 
S-Depression, S-Phobic anxiety
criterion: COPD-related disability in spouses (S-CDI)
Model C: patient variables from model A Model D: patient variables from model C plus SGRQ 
scores
Signiﬁ  cant Predictors: β p Signiﬁ  cant Predictors: β p
P-Somatizationa 
(SCL-90-R)
0.24 0.057 Impact 
(SGRQ)
0.46  0.001
Walking distance 
(SWT)
−0.36 0.016 P-Somatizationa 
(SCL-90-R)
0.22 0.024
P-Depression 
(SCL-90-R)
0.27 0.020
Excluded variables: 
SCL-90-R: P-Anxiousness, P-Phobic anxiety; P-Gender; P-depression/
anxiety diagnoses; FEV1 pred; heart disease
Excluded variables: 
SCL-90-R: P-Depression; Walking distance (SWT); FEV1% pred; 
heart disease; P-Gender; SGRQ: symptoms, activities; S-Gender
aScale without original items: chest pain/difﬁ  culties breathing
β = Stand. β –coefﬁ  cient.
Abbreviations: FEV1% pred, forced expiratory volume in 1 second expressed in percentage predicted; SWT, shuttle walking test; SCL-90-R, symptom-checklist-90-R; SGRQ, 
st. george’s respiratory questionnaire; P-..., patient variables; S-..., spouse variables.International Journal of COPD 2008:3(4) 734
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Intervention
Psychological disorders in patients should be treated 
pharmacologically and/or psychologically regardless of 
whether they are a direct consequence of the disease in the sense 
of an organic-related psychological disorder, an independent 
comorbid psychological disorder, or a reactive disorder. How-
ever, 70% of affected COPD patients refuse proposed pharma-
cological treatments (Yohannes et al 2001). This might be due 
to the large number of drugs already taken by such patients 
(on average 6.4, maximum of 17 in the present study).
Psychological interventions are often considered 
skeptically by patients and pneumologists. Hence it is 
important to point out the negative effects of increased anxiety 
or depression on the quality of life of COPD patients.
The high efﬁ  cacy of cognitive–behavioral approaches 
in the treatment of anxiety disorders (Mitte 2005) and 
depression disorders (Maat et al 2007) is beyond doubt. 
The efﬁ  cacy of additional psychological interventions in 
patients with other somatic diseases, such as chronic pain 
(Hoffman et al 2007) or cancer (Newell et al 2002) has also 
been demonstrated.
The efﬁ  cacy of psychological interventions in COPD 
patients with comorbid anxiety or depressive disorders is 
yet unclear (Coventry and Gellatly in press). There have 
only been a few studies with mostly small sample sizes. Two 
pilot studies (Lisansky and Clough 1996; Eiser et al 1997) 
reported improved quality of life (Lisansky and Clough 
1996) but no reduced levels of anxiety. In a controlled, 
randomized cognitive–behavioral study, a one-session 
short-term intervention could signiﬁ  cantly reduce anxious-
ness and depression in COPD patients (Kunik et al 2001). 
A small randomized controlled trial (RCT) (de Godoy and 
de Godoy 2003) showed signiﬁ  cantly decreased depres-
sion and anxiety levels after psychotherapy (including 
cognitive-behavioral interventions). Cognitive Behavioral 
Group Therapy (CBT) in COPD patients with clinically 
signiﬁ  cant symptoms of depression and anxiety resulted in 
a signiﬁ  cant improvement of their quality of life (Kunik et al 
2008). CBT did not differ from COPD education, however, 
which also resulted in signiﬁ  cant improvements regarding 
quality of life, anxiety und depression. In both treatment 
groups, improvements were maintained until follow-up. 
ICD-10 DSM-
IV
Diagnosis
F43.2 309.x Adjustment disorder 
F43.20 309.0 - with depressed mood
F43.28 309.24 - with anxiety
F43.22 309.28 - with mixed depressed mood and anxiety
F06.4 293.84 Anxiety disorder due to a general medical condition 
F06.3x 293.83 Mood disorder due to a general medical condition 
F32.9/F33.9 311 Depressive disorder not otherwise specified (NOS), within this  
category:
- Recurrent brief depressive disorder: depressive episodes 
lasting from 2 days up to 2 weeks, occurring at least one a 
month for 12 month
- Situations in which the clinician has concluded that a 
depressive disorder is present but unable to determine whether
it is primary, due to a general medical condition, or substance 
induced.
Figure 1 Diagnoses that warrant further consideration.International Journal of COPD 2008:3(4) 735
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However, it is questionable whether there was sufﬁ  cient time 
for individualized CBT interventions when using groups of 
10 participants (8 × 60 minutes).
Thus, in addition to the conventional COPD education 
and comprehensive pulmonary rehabilitations, which are 
effective in the short term (Coventry and Hind 2007), it is 
essential to establish appropriate short-term psychological 
interventions for COPD patients with psychological 
comorbidity by therapists trained in behavior medicine. 
Future research should therefore focus on the development 
and evaluation of effective psychological interventions for 
COPD patients with psychological comorbidities.
Spouses
The ﬁ  nding that the spouses’ anxiousness is a predictor for 
the health-related quality of life in patients underscores the 
importance of involving anxious spouses in intervention 
programs. Future studies will have to show whether this is 
a helpful tool to indirectly improve health-related quality of 
life in patients.
Further investigations and panel studies are needed 
to analyze the influence of other psychological factors 
(eg, satisfaction in the relationship, social support/distress, 
coping or avoidance of physical effort) on the quality of life 
of COPD patients.
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